Company / Operating Income per Share
MBX Biosciences, Inc. Operating Income per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.41
FY2024
5-year range
-$34.66 / -$6.41
FY2023-FY2024
Trend
+81.5%
vs FY2023
Sector context
#181 of 201
Health Care
What the data says
Among 201 Health Care companies, MBX Biosciences, Inc. is in the bottom 10% for operating income per share.
Based on SEC 10-K filings.
-6.41 in FY2024.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 201This company -$6.41 Sector average -$28.56
▼
+77.6% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 81.5% year-over-year.
- Ranks #181 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$6.41 | +81.5% |
| FY2023 | -$34.66 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026